 "Aurobindo arm TheraNym inks pact with MSD for biologics manufacturing")
Aurobindo Pharma Limited announced that its wholly owned subsidiary, TheraNym Biologics Private Limited, has signed a Master Service Agreement (MSA) with Merck Sharpe & Dohme Singapore Trading (MSD), effective May 31, 2024. TheraNym will invest around Rs 1,000 crore for the new facility.
This agreement follows previous disclosures by Aurobindo Pharma about expanding its biologics manufacturing facilities and exploring contract manufacturing operations (CMO) for biologicals.
Under the terms of the master service agreement, TheraNym will build a new manufacturing facility to produce products for MSD. The facility will be located at Borapatla (V), Hathnoora Mandal, Medak District, Telangana.
The agreement is expected to benefit both companies by allowing Aurobindo Pharma to enter the CMO market for biologicals and by providing MSD with a new manufacturing partner.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%